everolimus for TSC
Selected indexed studies
- Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives. (Ther Clin Risk Manag, 2019) [PMID:31440057]
- Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. (Eur J Paediatr Neurol, 2023) [PMID:37669572]
- Tuberous sclerosis: a review of the past, present, and future. (Turk J Med Sci, 2020) [PMID:32222129]
_Worker-drafted node — pending editorial review._
Connections
everolimus for TSC is a side effect of
Sources
- Rapamycin for longevity: the pros, the cons, and future perspectives. (2025) pubmed
- Everolimus. (2018) pubmed
- Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives. (2019) pubmed
- Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. (2023) pubmed
- Tuberous sclerosis: a review of the past, present, and future. (2020) pubmed
- Everolimus. (2014) pubmed
- Epileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy. (2023) pubmed
- PMID:30222273 (2017) pubmed
- Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial. (2018) pubmed
- Tuberous sclerosis complex. (2018) pubmed